LifeSci Acquisition II Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LSAQ research report →
Price Chart
About the company
LifeSci Acquisition II Corp. aims to complete a business combination, such as a merger, share exchange, asset or stock acquisition, recapitalization, or reorganization, with one or more entities in the healthcare industry. Established in 2019, the company is headquartered in New York, New York.
- CEO
- Andrew Ian McDonald
- IPO
- 2020
- HQ
- New York City, NY, US
Get TickerSpark's AI analysis on LSAQ
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- 52W High
- $12.68
- 52W Low
- $8.42
- 50D MA
- $9.91
- 200D MA
- $10.05
- Beta
- 0.00
- RSI (14)
- 16
- Avg Volume
- 36.60K
No earnings-call transcripts are available for LSAQ yet.
- Free Float
- 52.0%
- Shares Outstanding
- 116.73M
- Float Shares
- 60.68M
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 25, 21 | McDonald Andrew I | other | 138,591 |
| Aug 25, 21 | Rice Michael Yehuda | other | 138,591 |
| Nov 24, 20 | Rice Michael Yehuda | other | 3,146,453 |
| Nov 24, 20 | McDonald Andrew I | other | 3,146,453 |
| Nov 20, 20 | Janssen Scott | other | 0 |
| Nov 20, 20 | McDonald Andrew I | other | 0 |
| Nov 20, 20 | Rice Michael Yehuda | other | 0 |
| Nov 20, 20 | Dobkin David | other | 0 |
| Nov 20, 20 | Graham G. Walmsley | other | 0 |
| Nov 20, 20 | Barrett Elizabeth A. | other | 0 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our LSAQ coverage
Recent articles, reports, and earnings notes.
No research on LSAQ yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate LSAQ report →Why Is Science 37 (SNCE) Stock Up 9% Today?
investorplace.com · Mar 13
Science 37 Holdings, Inc. (SNCE) CEO David Coman on Q4 2021 Results - Earnings Call Transcript
seekingalpha.com · Mar 22
Science 37: Pioneering Decentralized Clinical Trials
seekingalpha.com · Jan 2
'SPACs Attack' Recap: Looking Back At 5 SPAC Deals, Rumors And Top Headlines
benzinga.com · May 8
U.S. IPO Weekly Recap: Breast Cancer Biotech Pops 158% In A 6-IPO Week
seekingalpha.com · Nov 22
LifeSci Acquisition II Corp. Announces Pricing of $75 Million Initial Public Offering
globenewswire.com · Nov 20
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.